ARROWHEAD PHARMACEUTICALS, INC. Logo

ARROWHEAD PHARMACEUTICALS, INC.

Biotechnology company developing RNAi therapies to treat intractable diseases.

ARWR | US

Overview

Corporate Details

ISIN(s):
US04280A1007
LEI:
Country:
United States of America
Address:
177 E COLORADO BLVD, 91105 PASADENA

Description

Arrowhead Pharmaceuticals, Inc. is a biotechnology company that develops medicines to treat intractable diseases by silencing the genes that cause them. The company utilizes its proprietary RNA interference (RNAi) platform to create therapies that target disease pathways previously considered 'undruggable.' Arrowhead's development pipeline is focused on a broad range of therapeutic areas, including cardiometabolic, pulmonary, neuromuscular, and liver diseases. The company advances a portfolio of clinical-stage candidates designed to address significant unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-10 22:54
S-3ASR
English 385.2 KB
2025-12-10 00:04
FORM 4
English 7.6 KB
2025-12-05 22:00 English 7.0 KB
2025-12-02 00:10
FORM 4
English 6.9 KB
2025-11-28 19:19 English 6.9 KB
2025-11-25 22:13
10-K
English 6.8 MB
2025-11-25 22:10
8-K
English 165.1 KB
2025-11-18 20:49
8-K
English 8.1 MB
2025-10-10 22:02
10-K/A
English 636.4 KB
2025-10-04 00:15
FORM 4
English 7.6 KB
2025-10-01 21:44 English 7.4 KB
2025-09-17 00:06
FORM 4
English 7.1 KB
2025-09-12 22:33 English 7.3 KB
2025-09-12 22:01
8-K
English 62.8 MB
2025-09-11 13:31
8-K
English 71.2 MB

Automate Your Workflow. Get a real-time feed of all ARROWHEAD PHARMACEUTICALS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ARROWHEAD PHARMACEUTICALS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ARROWHEAD PHARMACEUTICALS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ATAI Life Sciences N.V. Logo
Develops psychedelic-inspired therapies for mental health disorders.
United States of America
ATAI
Atea Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing oral antiviral therapies for serious viral diseases.
United States of America
AVIR
Athira Pharma, Inc. Logo
Biopharma firm developing small molecule therapeutics for neurodegenerative diseases.
United States of America
ATHA
ATOSSA THERAPEUTICS, INC. Logo
Clinical-stage biopharmaceutical company developing oncology medicines for breast cancer.
United States of America
ATOS
aTYR PHARMA INC Logo
Develops medicines based on tRNA synthetase biology for fibrosis and inflammation.
United States of America
ATYR
Aura Biosciences, Inc. Logo
Develops Virus-Like Drug Conjugates as targeted therapies for solid tumors.
United States of America
AURA
Aurinia Pharmaceuticals Inc. Logo
Biopharmaceutical company developing therapies for severe autoimmune diseases.
United States of America
AUPH
AURORA CANNABIS INC Logo
Global producer and distributor of cannabis for medical and recreational markets.
United States of America
ACB
Autolus Therapeutics plc Logo
Biopharmaceutical company developing programmed T cell therapies for cancer and autoimmune diseases.
United States of America
AUTL
AVACTA GROUP PLC Logo
Clinical-stage biotech developing targeted oncology drugs with a proprietary platform.
United Kingdom
AVCT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.